BioProcess Insider Interviews

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
One on One Interview - Julien Meissonnier, Vice President & Chief Scientific Officer at Catalent, sits down with Bioprocess Insider editor Dan Stanton to talk about his firm’s recent jump into the cell and gene therapy space, how new modalities are affecting the CDMO sector, and how industry is increasingly turning to innovative third-parties to tackle everything from advanced therapy complexity to COVID-19 therapeutics.
Sponsored By
Speaker
photo
VP & CSO
Catalent